Thromb Haemost 2007; 98(06): 1266-1275
DOI: 10.1160/TH07-03-0189
Platelets and Blood Cells
Schattauer GmbH

Enhanced platelet aggregation and activation under conditions of hypothermia

Ruben G. Xavier
1   Thrombosis and Haemostasis Group, Cardiovascular Medicine, University of Nottingham, Nottingham, UK
,
Ann E. White
1   Thrombosis and Haemostasis Group, Cardiovascular Medicine, University of Nottingham, Nottingham, UK
,
Susan C. Fox
1   Thrombosis and Haemostasis Group, Cardiovascular Medicine, University of Nottingham, Nottingham, UK
,
Robert G. Wilcox
1   Thrombosis and Haemostasis Group, Cardiovascular Medicine, University of Nottingham, Nottingham, UK
,
Stan Heptinstall
1   Thrombosis and Haemostasis Group, Cardiovascular Medicine, University of Nottingham, Nottingham, UK
› Author Affiliations
Further Information

Publication History

Received 13 March 2007

Accepted after resubmission 22 September 2007

Publication Date:
30 November 2017 (online)

Summary

The effects on platelet function of temperatures attained during hypothermia used in cardiac surgery are controversial. Here we have performed studies on platelet aggregation in whole blood and platelet-rich plasma after stimulation with a range of concentrations of ADP, TRAP, U46619 and PAF at both 28°C and 37°C. Spontaneous aggregation was also measured after addition of saline alone. In citrated blood, spontaneous aggregation was markedly enhanced at 28°C compared with 37°C. Aggregation induced by ADP was also enhanced. Similar results were obtained in hirudinised blood. There was no spontaneous aggregation in PRP but ADP-induced aggregation was enhanced at 28°C. The P2Y12 antagonist AR-C69931 inhibited all spontaneous aggregation at 28°C and reduced all ADP-induced aggregation responses to small, reversible responses. Aspirin had no effect. Aggregation was also enhanced at 28°C compared with 37°C with low but not high concentrations of TRAP and U46619. PAF-induced aggregation was maximal at all concentrations when measured at 28°C, but reversal of aggregation was seen at 37°C. Baseline levels of platelet CD62P and CD63 were significantly enhanced at 28°C compared with 37°C. Expression was significantly increased at 28°C after stimulation with ADP, PAF and TRAP but not after stimulation with U46619. Overall, our results demonstrate an enhancement of platelet function at 28°C compared with 37°C, particularly in the presence of ADP.

 
  • References

  • 1 Lewis FJ. Closure of arterial septal defects with the aid of hypothermia: experimental accomplishments and the report of one successful case. Surgery 1953; 33: 52-59.
  • 2 Pugsley W, Klinger L, Paschalis C. et al. The impact of microemboli during cardiopulmonary bypass on neuropsychological functioning. Stroke 1994; 25: 1393-1399.
  • 3 Roach GW, Kanchuger M, Mangano CM. et al. Adverse cerebral outcomes after coronary bypass surgery. Multicenter Study of Perioperative Ischemia Research Group and the Ischemia Research and Education Foundation Investigators. N Engl J Med 1996; 335: 1857-1863.
  • 4 Hall MW, Goodman PD, Alston SM. et al. Hypothermia- induced platelet aggregation in heparinized flowing human blood: identification of a high responder subpopulation. Am J Hematol 2002; 69: 45-55.
  • 5 Hall MW, Hopkins RO, Long JW. et al. Hypothermia- induced platelet aggregation and cognitive decline in coronary artery bypass surgery: a pilot study. Perfusion 2005; 20: 157-167.
  • 6 Valeri CR, MacGregor H, Cassidy G. et al. Effects of temperature on bleeding time and clotting time in normal male and female volunteers. Crit Care Med 1995; 23: 698-704.
  • 7 Romlin B, Petruson K, Nilsson K. Moderate superficial hypothermia prolongs bleeding time in humans. Acta Anaesth Scand 2007; 51: 198-201.
  • 8 Valeri CR, Feingold H, Cassidy G. et al. Hypothermia- induced reversible platelet dysfunction. Ann Surg 1987; 205: 175-181.
  • 9 Michelson AD, MacGregor H, Barnard MR. et al. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost 1994; 71: 633-640.
  • 10 Zucker MB, Borrelli J. Viscous metamorphosis produced by chilling and clotting. Thromb Diath Haemorrh 1960; 4: 424.
  • 11 Anstall HB, Hawkey CM. Observations on platelet clumping and related phenomena. Transfusion 1962; 2: 44.
  • 12 Kattlove HE, Alexander B. The effect of cold on platelets. I. Cold-induced platelet aggregation. Blood 1971; 38: 39-48.
  • 13 Zhang J, Wood J, Bergeron AL. et al. Effects of low temperature on shear-induced platelet aggregation and activation. J Trauma 2004; 57: 216-223.
  • 14 Scharbert G, Kalb M, Marschalek C. et al. The effects of test temperature and storage temperature on platelet aggregation: a whole blood in vitro study. Anesth Analg 2006; 102: 1280-1284.
  • 15 White JG, Krivit W. An ultrastructural basis for the shape changes induced in platelets by chilling. Blood 1967; 30: 625-635.
  • 16 Faraday N, Rosenfeld BA. In vitro hypothermia enhances platelet GPIIb-IIIa activation and P-selectin expression. Anesthesiology 1998; 88: 1579-1585.
  • 17 Straub A, Breuer M, Wendel HP. et al. Critical temperature ranges of hypothermia-induced platelet activation: possible implications for cooling patients in cardiac surgery. Thromb Haemost 2007; 97: 608-616.
  • 18 Straub A, Azevedo R, Beierlein W. et al. Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest. Thromb Haemost 2005; 94: 115-122.
  • 19 Crowe JH, Tablin F, Tsvetkova N. et al. Are lipid phase transitions responsible for chilling damage in human platelets?. Cryobiology 1999; 38: 180-191.
  • 20 Fox SC, Sasae R, Janson S. et al. Quantification of platelet aggregation and microaggregate formation in whole blood by flow cytometry. Platelets 2004; 15: 85-93.
  • 21 May J, Heptinstall S. Effects of anticoagulants used during blood collection on human platelet functions. In: Gibbins JM, Mahaut-Smith MP. ed. Platelets and megakaryocytes. Vol. 1, Methods Mol Biol 2004. 272: 3-11.
  • 22 Fareed J, Walenga JM, Iyer L. et al. An objective perspective on recombinant hirudin: a new anticoagulant and antithrombotic agent. Blood Coagul Fibrinolysis 1991; 2: 135-147.
  • 23 Saniabadi AR, Lowe GD, Madhok R. et al. Red blood cells mediate spontaneous aggregation of platelets in whole blood. Atherosclerosis 1987; 66: 175-180.
  • 24 Goldsmith HL, Bell DN, Braovac S. et al. Physical and chemical effects of red cells in the shear-induced aggregation of human platelets. Biophys J 1995; 69: 1584-1595.
  • 25 Armstrong R, May AJ, Losche W. et al. Factors that contribute spontaneous platelet aggregation and streptokinase- induced aggregation in whole blood. Thromb Haemost 1995; 73: 297-303.
  • 26 Fox SC, Burgess-Wilson M, Heptinstall S. et al. Platelet aggregation in whole blood determined using the Ultra-Flo 100 Whole Blood Platelet Counter. Thromb Haemost 1982; 48: 327-329.